Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Velu

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Archives of Dermatological Research|October 16, 2007
Skin biopsies in DC vaccines for stage III-IV melanoma patients: role of neutrophils?M Laporte, M Trakatelli, P Vereecken, et al.
European Journal of Immunology|April 1, 1994
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytesF Willems, A Marchant, J P Delville, et al.
The Journal of Experimental Medicine|February 1, 1993
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemiaC Gérard, C Bruyns, A Marchant, et al.
Clinical and Experimental Immunology|July 1, 1993
IL-5 in post-traumatic eosinophilic pleural effusionL Schandené, B Namias, A Crusiaux, et al.
Cell Transplantation|November 30, 2004
Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectorsL Tenenbaum, M Peschanski, C Melas, et al.
Gastrointestinal Endoscopy|July 1, 1998
Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseasesJ L Van Laethem, V Bourgeois, J Parma, et al.
Progress in Clinical and Biological Research|January 1, 1994
The protective role of interleukin-10 in endotoxin shockA Marchant, C Bruyns, P Vandenabeele, et al.
Journal De La Societe De Biologie|September 4, 2001
[Anti-tumor immunotherapy based on dendritic cells]M Toungouz, M Lambermont, T Velu, et al.
Transplantation|October 27, 1994
Effects of systemic administration of rIL-10 in an in vivo model of alloreactivityA Delvaux, V Donckier, C Bruyns, et al.
Leukemia & Lymphoma|February 1, 1997
Nature of the T lymphocytes in lymphocyte predominance Hodgkin's diseaseJ L Dargent, L Schandene, A Kornreich, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Archives of Dermatological Research|October 16, 2007
Skin biopsies in DC vaccines for stage III-IV melanoma patients: role of neutrophils?M Laporte, M Trakatelli, P Vereecken, et al.
European Journal of Immunology|April 1, 1994
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytesF Willems, A Marchant, J P Delville, et al.
The Journal of Experimental Medicine|February 1, 1993
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemiaC Gérard, C Bruyns, A Marchant, et al.
Clinical and Experimental Immunology|July 1, 1993
IL-5 in post-traumatic eosinophilic pleural effusionL Schandené, B Namias, A Crusiaux, et al.
Cell Transplantation|November 30, 2004
Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectorsL Tenenbaum, M Peschanski, C Melas, et al.
Gastrointestinal Endoscopy|July 1, 1998
Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseasesJ L Van Laethem, V Bourgeois, J Parma, et al.
Progress in Clinical and Biological Research|January 1, 1994
The protective role of interleukin-10 in endotoxin shockA Marchant, C Bruyns, P Vandenabeele, et al.
Journal De La Societe De Biologie|September 4, 2001
[Anti-tumor immunotherapy based on dendritic cells]M Toungouz, M Lambermont, T Velu, et al.
Transplantation|October 27, 1994
Effects of systemic administration of rIL-10 in an in vivo model of alloreactivityA Delvaux, V Donckier, C Bruyns, et al.
Leukemia & Lymphoma|February 1, 1997
Nature of the T lymphocytes in lymphocyte predominance Hodgkin's diseaseJ L Dargent, L Schandene, A Kornreich, et al.
Pageof 10